Status:
COMPLETED
Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Cmv Congenital
CMV Viremia
Eligibility:
All Genders
1-35 years
Phase:
NA
Brief Summary
The objectives of the protocol are to determine if a structured cognitive-behavioral interventional counseling of pregnant women can limit acquisition of human cytomegalovirus (HCMV) during pregnancy ...
Detailed Description
The proposed cognitive-behavioral intervention protocol to modify the risk of exposure and acquisition of HCMV in pregnant women will include a two components. The first component of the trial will co...
Eligibility Criteria
Inclusion
- Inclusion:
- Women in Ribeirao Preto who receive maternity care through the Hospital Das Clinicas, University of São Paulo and the Mater Hospital
- enrollment in prenatal care before 23 weeks gestation
- Exclusion:
- late enrollment in prenatal care, after 23 weeks gestation
- known major fetal anomalies or demise
- planned termination of pregnancy
- intention of the patient to deliver at a non-study hospital
- referral for high risk prenatal care
Exclusion
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03443791
Start Date
September 1 2022
End Date
December 1 2025
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo
São Paulo, Brazil